Navigation Links
Heart attacks/pneumonia falls short of national goals
Date:10/31/2007

Emergency departments across the nation are failing to meet national goals in treating many heart attack and pneumonia patients, according to a study by Johns Hopkins researchers published in the October issue of Academic Emergency Medicine.

In a survey that also found care levels dependent on race, geography and type of health insurance, the investigators studied records of 1,492 heart attack patients and 3,955 pneumonia patients seen at 544 emergency departments between 1998 and 2004 . Results showed only 40 percent ED compliance with recommended aspirin therapy and 17 percent with recommended beta blocker treatment of heart attack patients.

Only 69 percent of patients with pneumonia got recommended antibiotics, and fewer than half (46 percent) had blood oxygen levels assessed as recommended by the American Thoracic Society.

The Joint Commission regulating hospitals and the Centers for Medicare and Medicaid Services say all eligible heart attack and pneumonia patients presenting to EDs should receive aspirin/beta blocker therapy, or antibiotic and oxygen assessment, respectively. If these numbers are applied nationwide, we estimate that as many as 22,000 deaths a year could be prevented in the U.S. if ED caregivers followed practice standards, said Julius Pham, M.D., principal investigator for the study and assistant professor of medicine in the Johns Hopkins departments of Emergency Medicine and Anesthesiology and Critical Care Medicine. More resources should be directed at studying why this is happening and developing strategies to ensure that 100 percent of patients get the recommended treatments.

Also troubling, the Johns Hopkins researchers say, are racial, geographic and financial differences in access to recommended care.

Whites were 40 percent more likely to receive aspirin therapy than non-whites, while people going to EDs in the Northeast were 40 percent more likely to receive aspirin than simila
'/>"/>

Contact: Gary Stephenson
gstephenson@jhmi.edu
410-955-5384
Johns Hopkins Medical Institutions
Source:Eurekalert

Page: 1 2

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Epileptic Seizures Can Be Duec to Heart Problem
3. Bypass Heart Surgery Performed Without General Anesthesia
4. New CPR Guidelines issued by Heart Association
5. White Cells Count Can Predict Heart Attack Death Risk
6. Vitamins-The answer to Heart Disease?
7. Fight Heart disease and Pain with Meditation
8. Heart disease in the newborn is related to maternal malnutrition
9. New drug to treat Heart Attack and damaged tissue
10. Starvation in pregnant women can cause heart disease to their children
11. Individuals with sleep related breathing disorders more prone to heart disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...gies (LCT) Limited has published evidence outlinin...e islet cells and insulin production in a human pa...ansplant. The scientific paper published in the ...journal Xenotransplantation outlines how LCT has d...
...gh source of nutrition for many people around the ...aten in several forms, it is the key ingredient fo.... With Easter just round the corner an animal righ...nch a campaign on Wednesday urging people not to e...
...ed several genetic risk factors leading to prostat...s the first real evidence of the genetic basis of ...e Keck School of Medicine at the University of Sou... the researchers of the study. "It gives us the ...
... their obsession for that ‘bronzed and beautiful’ ...nd, opine researchers. // According to a report p... of Public Health, the increases in people going i...ming. This is particularly so when considered in ...
Other Medicine News:Health News:Transplanted Pig Cells in Human Produce Insulin 2Health News:Transplanted Pig Cells in Human Produce Insulin 3Health News:Sultans of Suntans Warned 2
(Date:9/4/2008)...zing Patient Identification for Targeted Therapies... Treatment HUNTINGTON BEACH, Calif., and AMSTER... a world leader in molecular cancer diagnostics,t... diagnostic test that,allows physicians to quantit...e estrogen receptor (ER), progesterone receptor (P...
(Date:9/3/2008)..., Sept. 3 /- Simcere,Pharma...er and supplier of,branded generic pharmaceuticals...ech product Endu (also known as Endostar) in China...linical study., At the request of the SFDA, Simce...validate the safety and therapeutic efficacy of En...
(Date:9/3/2008)...ium and GENEVA, Sept. 3 /- Artelis SA... CHO based monoclonal antibody,production with the...ams,per liter. This record level was accomplished ...) a high-performance stable Selexis CHO,production...cientists at,Selexis SA using their proprietary Se...
(Date:9/3/2008)...s Operations, Updates Zingo Launch Progress and Ad... Conference Call Today at 11:30 am...wire-FirstCall/ -- Anesiva,Inc. (Nasdaq: ANSV ) ...operations to focus on commercial and late-stage p... a specialty pharmaceutical pain management,compan...
Breaking Medicine Technology:Agendia Launches TargetPrint(R) for Breast Cancer Patients 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 2Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 2Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 4Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 5Core People Partners to Expand Services 15673 1Core People Partners to Expand Services 15673 2Sutter Opens Countys First Non Hospital Based Nuclear Imaging Option 15668 1Sutter Opens Countys First Non Hospital Based Nuclear Imaging Option 15668 2Sutter Opens Countys First Non Hospital Based Nuclear Imaging Option 15668 3Final Data From the SEISMIC Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1662 1Final Data From the SEISMIC Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1662 2Final Data From the SEISMIC Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1662 3Final Data From the SEISMIC Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1662 4Scientists solve mystery of polyketide drug formation 15662 1Scientists solve mystery of polyketide drug formation 15662 2
...and CAPTURE 2 Findings Suggest Improved Outcomes i...h 26, 2007 /PRNewswire-FirstCall/ --,Positive 30-d...rotid stenting can be performed with positive resu...erience in real-world,(non-clinical trial) setting... surgery. Interim results from the first 1,500,pat...
...Program to be Presented at Keystone Scientific Mee.../PRNewswire-FirstCall/ -- Rigel today announced th...rology, will be presenting,on the company,s effort... patients with the Human Immunodeficiency Virus (H... Columbia on March,27th and 29th. Dr. Jenkins will...
Other Medicine Technology:Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and,Effective Treatment to Reduce Risk of Stroke 2Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and,Effective Treatment to Reduce Risk of Stroke 3Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and,Effective Treatment to Reduce Risk of Stroke 4Rigel Ubiquitin Ligase Program Identifies Molecules With Anti-HIV,Activity 2Rigel Ubiquitin Ligase Program Identifies Molecules With Anti-HIV,Activity 3
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
Medicine Products: